LBO — ASPIRUS RHINELANDER HOSPITAL
IRR: 0.0% | MOIC: 0.00x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
0.0%
IRR
0.00x
MOIC
$-449.3M
Entry EV
$-673.3M
Exit EV
$-231.2M
Equity Invested
Sources & Uses
S&UTotal · $-449.3M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $-174.5M | 38.8% | |
| Sub Debt | $-43.6M | 9.7% | |
| Equity | $-231.2M | 51.5% | |
| Enterprise Value | $-436.2M | 97.1% | |
| Transaction Fees | $-13.1M | 2.9% | |
| Total Uses | $-449.3M | 100.0% |
Interpretation
INTAt 0.00x MOIC and 0.0% IRR over 5 years, this deal could not be computed.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $-64.1M |
| Exit Ev | $-673.3M |
| Net Debt At Exit | 0.0% |
| Equity At Exit | $-673.3M |
| Equity Invested | $-231.2M |
| Total Value Created | $-442.1M |
| Value From Growth | $-215.3M |
| Value From Multiple | $-21.8M |
| Value From Deleveraging | $-218.1M |